tetano
Editor, Senior Moderator
Am J Case Rep
. 2020 Oct 28;21:e927521.
doi: 10.12659/AJCR.927521.
Severe COVID-19 Pneumonia in a 30-Year-Old Woman in the 36th Week of Pregnancy Treated with Postpartum Extracorporeal Membrane Oxygenation
Watatu Takayama[SUP] 1 [/SUP], Akira Endo[SUP] 1 [/SUP], Junichiro Yoshii[SUP] 1 [/SUP], Hirokuni Arai[SUP] 2 [/SUP], Keiji Oi[SUP] 2 [/SUP], Eiki Nagaoka[SUP] 2 [/SUP], Satoshi Toyama[SUP] 3 [/SUP], Hiroto Yamamoto[SUP] 3 [/SUP], Tokujiro Uchida[SUP] 3 [/SUP], Yasuhiro Otomo[SUP] 1 [/SUP]
Affiliations
Abstract
BACKGROUND There are few reports of coronavirus disease 2019 (COVID-19) in pregnant women. Although coagulation dysfunction was reported to affect the severity of COVID-19, the association between pregnancy, which is usually accompanied by changes in coagulation function, and the worsening of COVID-19 is unknown. We present a case of a 30-year-old woman in the 36th week of pregnancy who was diagnosed with severe COVID-19 pneumonia and required postpartum extracorporeal membrane oxygenation (ECMO) therapy. CASE REPORT A 30-year-old, 36-weeks pregnant woman presented to our hospital and was diagnosed with severe COVID-19 pneumonia soon after she had undergone a cesarean section. Her respiratory failure could not be managed by conventional therapeutic approaches. Therefore, ECMO was administered on day 7. Controlling coagulation function to maintain ECMO therapy was challenging. Nafamostat mesylate and cryoprecipitate were administered to treat the hypercoagulative status and severe hypofibrinogenemia, respectively. Since coagulopathy and her respiratory state improved, the ECMO therapy was terminated on day 15. CONCLUSIONS We report a case of severe COVID-19 pneumonia in a pregnant woman urgently treated with ECMO in the postpartum period. Thus, this case highlights the importance of close monitoring and appropriate medical care for pregnant women with severe COVID-19 pneumonia.
. 2020 Oct 28;21:e927521.
doi: 10.12659/AJCR.927521.
Severe COVID-19 Pneumonia in a 30-Year-Old Woman in the 36th Week of Pregnancy Treated with Postpartum Extracorporeal Membrane Oxygenation
Watatu Takayama[SUP] 1 [/SUP], Akira Endo[SUP] 1 [/SUP], Junichiro Yoshii[SUP] 1 [/SUP], Hirokuni Arai[SUP] 2 [/SUP], Keiji Oi[SUP] 2 [/SUP], Eiki Nagaoka[SUP] 2 [/SUP], Satoshi Toyama[SUP] 3 [/SUP], Hiroto Yamamoto[SUP] 3 [/SUP], Tokujiro Uchida[SUP] 3 [/SUP], Yasuhiro Otomo[SUP] 1 [/SUP]
Affiliations
- PMID: 33110055
- DOI: 10.12659/AJCR.927521
Abstract
BACKGROUND There are few reports of coronavirus disease 2019 (COVID-19) in pregnant women. Although coagulation dysfunction was reported to affect the severity of COVID-19, the association between pregnancy, which is usually accompanied by changes in coagulation function, and the worsening of COVID-19 is unknown. We present a case of a 30-year-old woman in the 36th week of pregnancy who was diagnosed with severe COVID-19 pneumonia and required postpartum extracorporeal membrane oxygenation (ECMO) therapy. CASE REPORT A 30-year-old, 36-weeks pregnant woman presented to our hospital and was diagnosed with severe COVID-19 pneumonia soon after she had undergone a cesarean section. Her respiratory failure could not be managed by conventional therapeutic approaches. Therefore, ECMO was administered on day 7. Controlling coagulation function to maintain ECMO therapy was challenging. Nafamostat mesylate and cryoprecipitate were administered to treat the hypercoagulative status and severe hypofibrinogenemia, respectively. Since coagulopathy and her respiratory state improved, the ECMO therapy was terminated on day 15. CONCLUSIONS We report a case of severe COVID-19 pneumonia in a pregnant woman urgently treated with ECMO in the postpartum period. Thus, this case highlights the importance of close monitoring and appropriate medical care for pregnant women with severe COVID-19 pneumonia.